FGEN — Fibrogen Cashflow Statement
0.000.00%
Last trade - 00:00
- $103.45m
- -$0.32m
- $147.75m
- 30
- 35
- 66
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -77 | -189 | -290 | -294 | -284 |
Depreciation | |||||
Non-Cash Items | 62.5 | 74.2 | 133 | 66.7 | 76.7 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -85.7 | 175 | 60.1 | 70.4 | -117 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -78.7 | 81.6 | -82.2 | -146 | -315 |
Capital Expenditures | -5.76 | -3.99 | -30.2 | -38.7 | -2.52 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 126 | 456 | -397 | 128 | 156 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 120 | 452 | -427 | 89.1 | 154 |
Financing Cash Flow Items | -12.8 | -11.5 | -7.37 | -6.62 | -0.237 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4.3 | 13.3 | -0.563 | 46.8 | 123 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 37 | 552 | -507 | -15.5 | -42 |